Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autologous AD-MSC in Peritoneal Dialysis with Ultra Filtration Failure
NCT02801890Phase 2Completed
- Sponsor
- Royan Institute
- Start
- Aug 2015
- Primary completion
- Feb 2017
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of autologous adipose-derived mesenchymal stromal cells in peritoneal fibrosis (PF), Ultrafiltration Failure (UF), sponsored by Royan Institute. Started Aug 2015; status: completed.
02
Drugs
autologous adipose-derived mesenchymal stromal cells
03
Conditions
peritoneal fibrosis (PF)Ultrafiltration Failure (UF)
Beyond the preview
Go deeper on NCT02801890.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02801890.